| Literature DB >> 35464040 |
Yao Lu1, Bin Deng2, Luhua Xu2, Hanjiao Liu3, Yinzhi Song2, Fengxia Lin2.
Abstract
Rhodiola rosea (Golden Root Extract; RR) is an herbaceous perennial, which is native to high altitude areas, such as East Asia, Central Asia, Siberia, and North America. It has been studied for its positive pharmacological effects on health. However, only a handful of studies have evaluated the effects of RR as an exercise supplement for sport and physical activity. The aim of this study was to evaluate whether Rhodiola can be used as a supplement to improve human exercise ability. Studies were reviewed in accordance with the PRISMA guidelines and conducted between August and November, 2021. Databases searched included Cochrane, Embase, Web of Science, PubMed and East View Universal Database. Related terms were combined with keywords and MeSH subject headings using the corresponding Boolean operators: Rhodiola rosea, arctic root, roseroot, golden root, hongjingtian, and sports and exercise. A total of 10 papers were reviewed. Most of the studies reported that RR supplementation has a positive effect on athletic ability and sports performance, and no obvious adverse reactions were reported. Subjects taking RR showed a reduction in pain and muscle damage after exercise training, improved skeletal muscle damage, enhanced antioxidant capacity thereby reducing oxidative stress, reduced RPE scores, and improved athletic explosive power, but did not reduce the rating of perceived exertion (RPE) scores. RR appears to act as a safe and effective supplementation for sport and exercise.Entities:
Keywords: A systematic review; Rhodiola rosea; exercise; nutritional supplements; performance
Year: 2022 PMID: 35464040 PMCID: PMC9021834 DOI: 10.3389/fnut.2022.856287
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1Literature screening process.
Characteristics of the studies include.
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| Williams et al. ( | Randomized double-blinded, crossover, counterbalanced clinical trial | 10 Resistance-trained individuals (10 M) | 24.8 ± 5.6 years | Group1: 1,500 mg/day of Rhodiola rosea and took an additional 500 mg dose of corresponding treatment 30 min perid to exercise testing. | 3-day + 30 min prior | NOW Food Inc., Bloomingdale, IL, USA | Resistance exercise: 1set × 2 explosive reps at 75% of one-repetition maximum(1 RM), 3 sets × repetitions to failure (RTF) at 75% 1 RM |
| MedBallmann et al. ( | Randomized blinded and counter- balanced clinical trial | 11 Physically active participants (11 W) | 19.4 ± 0.8 years | Group1: Supplemented with 500 mg of Rhodiola rosea three times daily (~1,500 mg/day)and took an additional 500 mg dose of corresponding treatment 30 min prior to testing of each trial. | 3-day+30 min prior | NOW Food Inc., Bloomingdale, IL, USA | Completed 3 × 15 second Wingate Anaerobic Tests (WAnTs) |
| Lin et al. ( | Randomized double-blind, crossover clinical trial | 12 heathy subjects. (12 M) | 24.7 ± 0.5 years | Group1: Two Rhodiola rosea capsules (400 mg Rhodiola rosea per capsule) daily. | After 3-day exercise period and during 5-day recovery period | Standard Chem & Pharm Co., Taiwan | Continuous endurance exercise: 30-min run at 75% VO2max |
| Jowko et al. ( | Randomized double-blind clinical trial | 26 healthy students. (26 M) | PL: 20.9 ± 0.2 years. RR: 20.5 ± 0.3 years | Group1: 600 mg/day Rhodiola rosea | 4 weeks before exercise test | Naturell, Sweden | Incremental cycle ergometer tests |
| Duncan et al. ( | Double-blind crossover clinical trial | 10 healthy young individuals and recreation exercisers. (10 M) | 26 ± 6 years | Group1: 3 mg/kg body mass of Rhodiola rosea placed in a colored, opaque gelatin capsule. | 60 min before exercise test | Indigo Herbs, Glastonbury, UK | Resistance exercise: completed two 30-min submaximal cycling trials at a workload of 70% VO2maxin a fasted state |
| Shanely et al. ( | Randomized double-blind clinical trial | 48 runners. (35 M and 13 W) | 25–65 years | Group1: 600 mg/day Rhodiola rosea extract before running a marathon (2 Rhodiola rosea capsule and each capsule contained 300 mg of Rhodiola rosea extract). | 30 days prior to and the day of the marathon and seven days after marathon | PL Thomas & Co., Inc. (Morristown New Jersey) | A competitive marathon |
| Noreen et al. ( | Randomized double-blind,crossover clinical trial | 18 recreationally active subjects. (18 W) | 22 ± 3.3years | Group1: 3 mg/kg of Rhodiola rosea. | 1 h before test | Bulknutrition.com, Northborough, MA, USA | 10-min warm-up followed by a simulated 6-mile time trial on a variable grade course using the Velotron electronic bicycle ergometer |
| Parisi et al. ( | Double-blind clinical trial | 14 well-trained athletes. (14 M) | 25 ± 5 years | Group1: 170 mg/day Rhodiola rosea. | 4 weeks before exercise test | Unspecified | Cardio-pulmonary exhaustion test with the cycloergometer at 75% VO2max |
| Skarpanska- Stejnborn et al. ( | Randomized double-blind clinical trial | 22 professional rowers. (22 M) | PL: 21.0 ± 0.9 years. RR: 20.4 ± 1.2 years | Group1: 100 mg of Rhodiola rosea extract twice daily. | 4 weeks before exercise test | Unspecified | 2,000-m maximum test on a rowing ergometer |
| Walker et al. ( | Randomized double-blind clinical trial | 12 resistance -trained subjects. (12 M) | 29.92 ± 4.51 years | Group1: 1,500 mg/day Rhodiola rosea and 1,000 mg the day of the test. | 3-day + the day of the test | Bali Herbal, Singapore | Incremental forearm wrist flexion exercise to volitional fatigue |
Outcome variables and main results.
|
|
|
|
|---|---|---|
| Williams et al. ( | pre-(PRE), immediately post-(POST) exercise:LA, EPI, NE. Mean barbell velocity and total volume performed | Mean concentric velocity was significantly higher with GRE compared to PL ( |
| MedBallmann et al. ( | Mean watts, mean anaerobic capacity, mean anaerobic power, mean peak watts, mean total work, mean fatigue index | Mean watts ( |
| Lin et al. ( | before,immediately after,and1,2,24,48,72,and 120 h after :CK,LA, IL-1beta,IL-6, TNF-α, and CRP | At 24 and 48 h after the exercise,CK levels were higher than those before exercise in both groups.T he blood variables had returned to the baseline level at 24 h after exercise except the CK level. The CK levels were lower in the group 1 than that in the group 2 72 h after continuous exercise(208.2 ± 32.7 vs.136.7 ± 13.8U/L, |
| Jowko et al. ( | VO2 peak, TTE, PLT, and LAmax, HR values, Pmax, LArest | VO2 peak, TTE, PLT, and LAmax, as well as HR values did not change significantly in either group. Significant decrease in peak power (Pmax) in PL group in TermII as compared to TermI ( |
| Duncan et al. ( | Rest, 10, 20, and 30 min into the exercise: Heart rate; RPE; BRUMS; pleasure after exercise; rate of total carbohydrate oxidation | RPE was lower at 30 min into exercise for group 1 versus placebo ( |
| Shanely et al. ( | The day before,15 min post-and 1.5 h post-marathon: vertical jump and DOMS. Blood sample:Mb, CPK, AST, ALT, IL-6, IL-8, IL-10, MCP-1, G-CSF, CRP, eHSP72 | Intake RR supplementation did not attenuate the post-marathon decreased in muscle function, or increases in muscle damage, DOMS, eHSP72, or plasma cytokines in experienced runners, and the magnitude of change did not differ between groups |
| Noreen et al. ( | RPE, Blood lactate concentration, salivary cortisol, salivary alpha amylase, heart rate, time to completion, average power | During the standardized warm-up the average heart rate ( |
| Parisi et al. ( | HR Max, Borg Scale level, VO2max, TAS, CK, GLU, FFAs, MDA | Blood antioxidant status,inflammatory parameters, blood glucose,HR Max,Borg Scale level,VO2max and duration of the test were essentially unaffected by RR but plasma free fatty acids levels were reduced. Blood lactate and plasmacreatine kinase levels were found significantly lower ( |
| Skarpanska-Stejnborn et al. ( | Power Output, blood lactate (La) Levels, total run time, SOD, GPx, UA, TAC, CK, TBARS | The total plasma antioxidant capacity was significantly higher ( |
| Walker et al. ( | During exercise and recovery from exercise: PC, rating of perceived exertion per stage, time to exhaustion | There were no significant differences between groups for PC, rating of perceived exertion per stage, time to exhaustion. RR ingestion does not improve ATP turnover during or immediately after exercise |